Tower Research Capital LLC (TRC) - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 34 filers reported holding SEELOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$10,052
+1005100.0%
8,412
+370.7%
0.00%
Q1 2023$11,787
+2220.8%
0.00%
Q4 2022$0770.0%0.00%
Q3 2022$0
-100.0%
77
-99.1%
0.00%
Q2 2022$6,000
-57.1%
8,291
-49.2%
0.00%
Q1 2022$14,000
-70.8%
16,313
-44.9%
0.00%
-100.0%
Q4 2021$48,000
+84.6%
29,595
+169.6%
0.00%0.0%
Q3 2021$26,000
-10.3%
10,977
-1.5%
0.00%0.0%
Q2 2021$29,000
-61.8%
11,140
-26.6%
0.00%0.0%
Q1 2021$76,000
+3700.0%
15,174
+787.9%
0.00%
Q3 2020$2,000
-75.0%
1,709
-78.6%
0.00%
Q2 2020$8,0007,9690.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders